High-sensitivity troponin I and all-cause mortality in patients with stable COPD: An analysis of the COSYCONET study.
Chronic obstructive pulmonary disease (COPD) is a leading cause of death with a considerable part of the population dying from cardiovascular diseases. High-sensitivity troponin I (hs-TnI) might help to better identify COPD patients at high risk of mortality. We aimed to study the predictive value of hs-TnI for all-cause mortality beyond established COPD assessments, and after consideration of relevant cardiovascular risk factors and prevalent cardiovascular diseases, in a broad population with stable COPD.Circulating hs-TnI concentrations together with a wide range of respiratory and cardiovascular markers were evaluated in 2085 patients with stable COPD across all severity stages enrolled in the multi-center COSYCONET cohort study. The primary outcome was all-cause mortality over 3 years of follow-up.Hs-TnI was detectable in 2020 (96.9%) patients. The median hs-TnI concentration was 3.8 ng·L-1 (IQR, 2.5‒6.6 ng·L-1) with levels above the 99th percentile reference limit of 27 ng·L-1 observed in 1.8% patients. In Cox regression analyses including adjustments for airflow limitation, dyspnea grade, exercise capacity, and history of severe exacerbations, as well as traditional cardiovascular risk factors, estimated glomerular filtration rate, ankle-brachial index, N-terminal pro-brain natriuretic peptides, and prevalent cardiovascular diseases, hs-TnI was a significant predictor for all-cause mortality, both as a continuous variable (HR for log hs-TnI, 1.28 [95%CI, 1.01‒1.62]) and categorised according to the cut-off of 6 ng·L-1 (HR, 1.63 [95%CI, 1.10‒2.42]).In patients with stable COPD, hs-TnI is a strong predictor of all-cause mortality beyond established COPD mortality predictors, and independent of a broad range of cardiovascular risk factors and prevalent cardiovascular diseases. Hs-TnI concentrations well-below the upper reference limit provide further prognostic value for all patients with COPD when added to established risk assessments.